top of page

Reviewing of term sheet for licensing technology for Aptimmune Biologics

Collyer Law advised Aptimmune Biologics, Inc, a US based company which specializes in developing revolutionary mucosal vaccines, made with Barricade (TM) Formulation Technology, in connection with reviewing of term sheet for licensing technology.

Tags:

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square
bottom of page